What medication is recommended for treating an acute pseudogout flare in a painful knee with calcium pyrophosphate crystals on joint aspiration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment for Acute Pseudogout (Calcium Pyrophosphate Crystal Arthritis)

For your painful knee with confirmed calcium pyrophosphate crystals, start with either oral corticosteroids (prednisolone 30-35 mg daily for 3-5 days), NSAIDs with gastroprotection, or low-dose colchicine (1 mg loading dose followed by 0.5 mg one hour later), choosing based on your kidney function, comorbidities, and contraindications.

First-Line Treatment Options

The 2011 EULAR guidelines specifically for CPPD disease recommend a structured approach 1:

Immediate Non-Pharmacological Measures

  • Apply ice or cool packs to the affected knee
  • Temporary rest with weight restriction
  • Joint aspiration alone may provide significant relief by reducing painful intra-articular pressure

Pharmacological Treatment Algorithm

Option 1: Intra-articular Corticosteroid Injection (Preferred if monoarticular)

  • Aspirate the joint fluid, then inject long-acting corticosteroid directly into the knee
  • This approach is highly effective and avoids systemic side effects 1
  • Particularly useful in older patients with multiple comorbidities

Option 2: Oral Corticosteroids (Often Best Risk-Benefit Ratio)

  • Prednisolone 30-35 mg daily for 3-5 days 2
  • Recent evidence suggests corticosteroids provide the best benefit-risk ratio for acute CPP crystal arthritis 3
  • Safer than NSAIDs in older patients with renal impairment or cardiovascular disease 4
  • Short courses minimize risks of hyperglycemia, immune suppression, and fluid retention

Option 3: NSAIDs with Gastroprotection

  • Any NSAID is acceptable (no evidence one is superior to another) 4
  • Must add proton pump inhibitor if indicated 2
  • Avoid if you have: severe renal impairment, heart failure, cirrhosis, or history of GI bleeding 1

Option 4: Low-Dose Colchicine

  • Loading dose: 1 mg followed by 0.5 mg one hour later 4
  • Then 0.5 mg 2-3 times daily as needed 1
  • Avoid if you have: severe renal impairment or are taking strong CYP3A4/P-glycoprotein inhibitors (cyclosporine, clarithromycin) 2
  • Risk of diarrhea but generally well-tolerated at low doses 3

Critical Decision Points

Choose Based on Your Clinical Context:

If you are older (>65 years) with multiple comorbidities:

  • Intra-articular corticosteroid injection is safest
  • If systemic therapy needed, oral corticosteroids preferred over NSAIDs 1

If you have normal kidney function and no GI risk factors:

  • NSAIDs with PPI or oral corticosteroids are both reasonable
  • Colchicine is effective but may cause diarrhea

If you have severe renal impairment:

  • Avoid NSAIDs and colchicine entirely 2
  • Use corticosteroids (intra-articular or short oral course)

If septic arthritis cannot be definitively excluded:

  • Do NOT use corticosteroids until infection is ruled out 1
  • Send synovial fluid for culture and Gram stain

Important Caveats

The Evidence Base

While the guidelines above are from EULAR 2011 specifically for CPPD 1, much of the evidence is extrapolated from gout studies. The American College of Physicians 2017 guidelines 4 and EULAR 2016 gout guidelines 2 provide high-quality evidence for these same medications in crystal arthritis, supporting their use in pseudogout.

Common Pitfalls to Avoid

  • Don't use high-dose colchicine regimens (the old 0.5 mg every 2 hours approach causes 100% incidence of severe diarrhea) 1
  • Don't combine NSAIDs with systemic corticosteroids due to synergistic GI toxicity risk 5
  • Don't forget gastroprotection when using NSAIDs, especially in older patients 2
  • Don't start treatment before confirming diagnosis - synovial fluid analysis showing positively birefringent rhomboid CPP crystals is essential 1, 3

If Symptoms Don't Improve

For refractory cases or contraindications to all first-line options:

  • Consider IL-1 blockers (anakinra) 6, 3
  • Requires rheumatology consultation
  • Contraindicated if active infection present 2

Long-Term Considerations

If you experience recurrent attacks (≥2 per year):

  • Prophylactic low-dose colchicine 0.5-1 mg daily can prevent flares 1, 3
  • Consider screening for metabolic conditions: hyperparathyroidism, hemochromatosis, hypomagnesemia, hypophosphatasia 1, 3
  • Hydroxychloroquine or low-dose methotrexate are options for chronic CPP crystal inflammatory arthritis 1, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.